Content |
History
2021: Announcement of the creation of the Biopolis SEZ, investments will amount to 20.5 billion rubles
In mid-December 2021, the governor of the Kirov region Igor Vasiliev announced the creation of a special economic zone (SEZ) in the region in the field of biopharmaceutics and immunobiology "Biopolis." Investments in this project will amount to 20.5 billion rubles.
 | Within its borders, a new administrative territorial unit will be created - a municipal district, a modern scientific and production complex will be formed there, it is planned to build a branch of the Chumakov Institute, a world leader in vaccine development, all the infrastructure necessary for a comfortable life and work will appear: social, housing, production, "Vasiliev said, speaking to deputies of the Legislative Assembly of the region (quote from TASS). |  |
According to him, it is planned to attract about 18 billion rubles of extrabudgetary and 2.5 billion rubles of budget investments in the creation of the infrastructure of the Biopolis SEZ, as well as create an additional 1200 "high-performance jobs."
The Biopolis SEZ will be created in the Orichevsky district of the region, where in 2019 the Biopolis Scientific and Educational Center (NOC) was opened, whose activities are aimed at combining the science, education and production potential of the region.
Since 2018, a biopharmaceutical cluster has been operating in the region, which included 17 operating enterprises, the center was the company Nanolek"," which is actively developing production facilities.
In mid-December 2021, Nanolek signed an agreement with the Governor of the Kirov Region Igor Vasiliev on cooperation with the aim of creating Biopolis on the basis of the village of Levintsy. As specified in the press service of the company, within ten years Biopolis plans to open schools with biotechnological specialization, a scientific and educational center and a branch of the Center named after M.P. Chumakov, specializing in vaccine development.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |